Clinical Study of Self-gripping Mesh in TAPP Versus Lichtenstein Hernia Repair
1 other identifier
interventional
130
1 country
1
Brief Summary
The goal of this prospective study is to compare the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair, in order to improve the outcome of inguinal hernia treatment. The main question it aims to answer is, in which procedure is the self-gripping mesh more effective. Participants will be divided into the TAPP group and the Lichtenstein group by random number table method, the TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair, and the Lichtenstein group underwent Lichtenstein hernia repair, both groups used self-gripping meshes. Researchers will compare the operation time, postoperative time out of bed, postoperative hospital stay, hospital costs and postoperative complications between the two groups to see the clinical efficacy of self-gripping mesh in laparoscopic transabdominal preperitoneal versus Lichtenstein hernia repair.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
January 26, 2024
CompletedFirst Posted
Study publicly available on registry
February 5, 2024
CompletedFebruary 6, 2024
February 1, 2024
1.8 years
January 26, 2024
February 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of moderate to severe pain at 3 and 6 months after surgery.
Visual analogue scale (VAS) was used to score the postoperative pain at 3 and 6 months. The score ranges from 0 (no pain) to 10 (most severe pain).
3 and 6 months after surgery.
Secondary Outcomes (1)
Incidence of recurrent inguinal hernia at 3 and 6 months after surgery.
3 and 6 months after surgery.
Study Arms (2)
TAPP group
EXPERIMENTALThe TAPP group underwent laparoscopic transperitoneal preperitoneal hernia repair.
Lichtenstein group
EXPERIMENTALThe Lichtenstein group underwent Lichtenstein hernia repair.
Interventions
The TAPP group used self-gripping mesh for laparoscopic transperitoneal preperitoneal hernia repair.
The Lichtenstein group used self-gripping mesh for Lichtenstein hernia repair.
Eligibility Criteria
You may qualify if:
- Male patients aged 18 years and older.
- Patients with a definite diagnosis of unilateral primary inguinal hernia.
- Patients and their families were informed about the study protocol and agreed to participate in the study.
You may not qualify if:
- Patients with femoral, recurrent, bilateral, incarcerated and strangulated hernias.
- Patients with previous history of lower abdominal surgery.
- Patients with contraindications to anaesthesia.
- Patients with contraindications to laparoscopic surgery.
- Failure to follow up patients as scheduled.
- Patients with abdominal infections.
- Those who cannot tolerate general anaesthesia surgery due to serious coagulation disorders, cardiopulmonary disorders, etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Second Hospital of Jilin University
Changchun, Jilin, 130022, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 26, 2024
First Posted
February 5, 2024
Study Start
March 1, 2022
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
February 6, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
Data sharing with other researchers is not planned at this time due to patient privacy concerns.